Home › Funds › Soleus Capital Management, L.P. › NRIX
Soleus Capital Management, L.P. position in NRIX
NURIX THERAPEUTICS INC · Health Care
Soleus Capital Management, L.P. reported holding 892,163 shares of NRIX (NURIX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.2M, representing 0.75% of its reported portfolio and ranking #30 among its reported holdings. Soleus Capital Management, L.P. has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s NRIX position evolved
Soleus Capital Management, L.P. first disclosed a stake in NRIX in Q3 2023 at 814,000 shares (US$6.4M). The position peaked in Q2 2024 at 2,055,916 shares, worth US$42.9M. Across 13 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 892,163 shares valued at US$21.2M — a reduction of -573,000 shares quarter over quarter.. Notable position changes include a 680% increase in Q1 2024 (shares rose 42% over the following quarter), a 84% increase in Q2 2024 (shares rose 8% over the following quarter), a 97% increase in Q4 2024 (shares fell 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 814.00K | $6.40M | New |
| Q4 2023 | 143.00K | $1.48M | Reduce |
| Q1 2024 | 1.11M | $16.39M | Add |
| Q2 2024 | 2.06M | $42.91M | Add |
| Q3 2024 | 1.07M | $23.95M | Reduce |
| Q4 2024 | 2.10M | $39.62M | Add |
| Q1 2025 | 2.42M | $28.78M | Add |
| Q2 2025 | 2.42M | $27.60M | Hold |
| Q3 2025 | 2.42M | $22.39M | Hold |
| Q4 2025 | 1.22M | $23.13M | Reduce |
| Q1 2026 | 938.16K | $14.54M | Reduce |
| Q2 2026 | 1.47M | $35.54M | Add |
| Q3 2026 | 892.16K | $21.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NRIX and 13F data
NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in NRIX — the largest reported positions include Redmile Group, LLC (US$187.3M), Vestal Point Capital, LP (US$166.6M), Deep Track Capital, LP (US$142.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NRIX
- Redmile Group, LLC 7.90M sh · $187.33M · Q3 2026
- Vestal Point Capital, LP 7.03M sh · $166.56M · Q3 2026
- Deep Track Capital, LP 6.00M sh · $142.26M · Q3 2026
- PERCEPTIVE ADVISORS LLC 5.37M sh · $127.36M · Q3 2026
- Rubric Capital Management LP 4.97M sh · $117.76M · Q3 2026
- BAKER BROS. ADVISORS LP 4.66M sh · $110.45M · Q3 2026
- GENERAL ATLANTIC, L.P. 3.03M sh · $71.89M · Q3 2026
- Trails Edge Capital Partners, LP 1.57M sh · $37.30M · Q3 2026
- Kynam Capital Management, LP 1.19M sh · $28.33M · Q3 2026
- Affinity Asset Advisors, LLC 967.62K sh · $22.94M · Q3 2026
- BRAIDWELL LP 871.10K sh · $20.65M · Q3 2026
- ADAR1 Capital Management, LLC 813.24K sh · $19.28M · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held NRIX?
Soleus Capital Management, L.P. has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in NRIX?
As of Q3 2026, Soleus Capital Management, L.P. holds 892.16K shares of NRIX (NURIX THERAPEUTICS INC), valued at $21.15M, representing 0.75% of its reported portfolio and ranking #30.
Has Soleus Capital Management, L.P. been buying or selling NRIX?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. reduced its position in NRIX. The position peaked in Q2 2024 at 2.06M shares.
Which other funds hold NRIX?
Other major institutional holders of NRIX include Redmile Group, LLC, Vestal Point Capital, LP, Deep Track Capital, LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.